RESOLYS BIO, Inc.

ABOUT

Formed in February of 2016 as a spinout by Beech Tree Labs, Inc. (BTL), Resolys Bio is a privately held clinical-stage biotechnology company focusing on therapeutic agents for chronic disorders for which there is little or no competition. The lead indications of Resolys Bio  are traumatic brain injury (TBI) and chronic tissue disorders such as Joint Hypermobility Syndromes (JHS), Lupus, Rheumatoid Arthritis, and Fibromyalgia.

OTHER INFORMATION:

  • moderate chronic concussion resolution
  • $6-8 mm in equity
  • internal memo imminent
  • not  yet engaged

 

EXEMPLAR CONTACT

Andrew Szabo

aszabo@exemplarcapital.com

917-796-8500

More Capital Deals

Neal Sampat

Neal Sampat

Meet The Team   We're Fun, Social & Business Savvy.  Neal Sampat Special Counsel, Exemplar Law, LLC AT EXEMPLAR Work Smart, Have Fun - See Us At Play Contracts/Business Law Entertainment Law Trademarks Estate Planning WHATS YOUR SUPERPOWER? My superpower is...

read more
J. Cooper Cordin

J. Cooper Cordin

Meet The Team   We're Fun, Social & Business Savvy.  J. Cooper Cordin Managing Director, Exemplar Capital, LLC AT EXEMPLAR Work Smart, Have Fun - See Us At Play Alternative Investments Capital Markets Strategic Partnerships Consulting GTM Strategies WHATS...

read more
Reginald Sewell

Reginald Sewell

Meet The Team   We're Fun, Social & Business Savvy.  Reginald Sewell Transactional Attorney, Exemplar Law, LLC AT EXEMPLAR Work Smart, Have Fun - See Us At Play Corporate Transactional Law Mergers and Acquisitions Private Equity Securities and General...

read more